ヨーロッパのダウン症候群市場 – 業界動向と2028年までの予測

Customize Your Report レポートをカスタマイズする Buy Now 今すぐ購入 Free Sample Report 無料サンプルレポート
Home Pharmaceutical ヨーロッパのダウン症候群市場
Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Buy Now今すぐ購入 Inquire Before Buying 事前に問い合わせる Free Sample Report 無料サンプルレポート

ヨーロッパのダウン症候群市場 – 業界動向と2028年までの予測

  • Pharmaceutical
  • Published Report
  • Mar 2021
  • Europe
  • 350 ページ
  • テーブル数: 238
  • 図の数: 18
Buy Now 今すぐ購入

>ヨーロッパのダウン症候群市場、疾患タイプ別（21トリソミー、転座ダウン症候群、モザイクダウン症候群）、治療（診断、治療）、エンドユーザー別（病院、診療所、在宅ケア環境、治療センター、その他）、流通チャネル別（直接入札、小売販売、その他）、国別（ドイツ、英国、フランス、イタリア、スペイン、ロシア、ポーランド、スイス、オランダ、ハンガリー、オーストリア、ノルウェー、アイルランド、トルコ、リトアニア、その他のヨーロッパ諸国）2028年までの業界動向と予測

ヨーロッパのダウン症市場市場分析と洞察: ヨーロッパのダウン症市場

ダウン症候群市場は、2021年から2028年の予測期間に市場成長を遂げると予想されています。データブリッジマーケットリサーチは、市場は2021年から2028年の予測期間に13.78%のCAGRで成長し、2028年までに7億2,512万米ドルに達すると分析しています。ダウン症候群に関する意識の高まりと罹患率の増加は、予測期間における市場の需要を推進する主な原動力です。

技術の進歩と政府の支援の増加は、予測期間中にダウン症候群市場の需要を押し上げた主な原動力です。

ダウン症候群は、異常な細胞分裂が原因で起こる遺伝病です。異常な細胞分裂により、染色体 21 の完全または部分的なコピーが過剰に発生します。余分な遺伝物質が存在すると、ダウン症候群につながる身体的および発達的変化が起こります。ダウン症候群に関連する最も一般的な遺伝的異常には、主に子供の学習障害などの精神障害があります。

ダウン症候群に対する認識が高まったことにより、人々は健康的なライフスタイルを築くために、先進的な治療法とともに新しい診断アプローチを選択できるようになりました。これは、この病気に対する認識の高まりがダウン症候群市場の成長の原動力となっていることを意味します。合併症は、特定の治療法が利用できないことがダウン症候群市場の成長の抑制要因となっていることを示しています。ダウン症候群市場で活動している市場プレーヤーは、ダウン症候群市場の成長の機会として機能するさまざまな側面でビジネスを活性化すると予想されるいくつかの戦略的イニシアチブを採用しています。製品の発売に関連する長い承認時間は、ダウン症候群市場の成長に対する課題となっています。

ダウン症候群市場レポートでは、市場シェア、新開発、製品パイプライン分析、国内および現地の市場プレーヤーの影響の詳細、新たな収益源、市場規制の変更、製品承認、戦略的決定、製品発売、地理的拡大、市場における技術革新の観点から見た機会の分析が提供されます。分析とダウン症候群市場のシナリオを理解するには、アナリスト概要について Data Bridge Market Research にお問い合わせください。当社のチームが、希望する目標を達成するための収益影響ソリューションの作成をお手伝いします。

ヨーロッパのダウン症市場ダウン症市場の範囲と市場規模

ダウン症候群市場は、疾患の種類、治療、エンドユーザー、流通チャネルに基づいてセグメント化されています。セグメント間の成長は、ニッチな成長分野と市場へのアプローチ戦略を分析し、コアアプリケーション領域とターゲット市場の違いを決定するのに役立ちます。

  • 疾患の種類に基づいて、ダウン症候群市場は、21トリソミー、転座ダウン症候群、モザイクダウン症候群に分類されます。2021年には、ダウン症候群の症例の95％以上が21トリソミーであるため、21トリソミーセグメントが市場を支配しています。
  • 治療に基づいて、ダウン症候群市場は診断と治療に分かれています。2021年には、ほとんどの親が胎児の状態を把握するために出生前検査を受けるため、診断セグメントが市場を支配しています。
  • ダウン症候群市場は、エンドユーザーに基づいて、病院、診療所、在宅ケア環境、治療センターなどに分割されています。2021年には、出生前検査の主な施設である病院セグメントが市場を支配しています。
  • 流通チャネルに基づいて、ダウン症候群市場は直接入札、小売販売、その他に分類されます。2021年には、病院や診療所による診断製品の購入の主な方法であるため、直接入札セグメントが市場を支配しています。

ダウン症市場の国別分析

ダウン症候群市場は分析され、市場規模の情報は、上記のように国、病気の種類、治療法、エンドユーザー、流通チャネル別に提供されます。

ダウン症候群市場レポートで取り上げられている国は、ドイツ、イギリス、フランス、イタリア、スペイン、ロシア、ポーランド、スイス、オランダ、ハンガリー、オーストリア、ノルウェー、アイルランド、トルコ、リトアニア、その他のヨーロッパ諸国です。

ダウン症候群の診断はほとんどの国で日常的な検査となっているため、ヨーロッパは予測期間中に最も高い CAGR で成長すると予想されています。ドイツはヨーロッパ市場で優位に立つと予想されています。ドイツはヨーロッパで巨大な市場の可能性を秘めており、ダウン症候群の診断に対する需要が高い主要国の一つです。

レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、国別データの予測分析を提供する際には、ヨーロッパ ブランドの存在と可用性、および地元および国内ブランドとの競争が激しいか少ないために直面​​する課題、販売チャネルの影響も考慮されます。

政府の支援の増加と研究開発の増加がダウン症の市場成長を後押ししている

ダウン症候群市場では、ダウン症候群の医薬品の売上、ダウン症候群の技術の進歩の影響、ダウン症候群市場へのサポートに関する規制シナリオの変化など、ダウン症候群産業の各国での成長に関する詳細な市場分析も提供しています。データは、2010年から2019年までの履歴期間で利用可能です。

競争環境とダウン症の市場シェア分析

ダウン症候群市場の競争状況は、競合他社ごとに詳細を提供します。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品試験パイプライン、製品の承認、特許、製品の幅と広さ、アプリケーションの優位性、技術ライフライン曲線が含まれます。提供されている上記のデータ ポイントは、ダウン症候群市場に関連する会社の焦点にのみ関連しています。

ダウン症候群を扱う主要企業には、F. Hoffmann-La Roche Ltd、PerkinElmer Inc.、Illumina, Inc.、Thermo Fisher Scientific Inc.、Myriad Genetics, Inc.、Abbott、Natera, Inc、AtilaBiosystems、Physio.co.uk、Novus Biologicals (Bio-Techne の子会社)、Down Syndrome Cork (Down Syndrome Ireland の支社)、Demeditec Diagnostics GmbH、Symbol、ASDclinic.co.uk など、国内企業があります。DBMR アナリストは、競争上の強みを理解し、各競合他社の競合分析を個別に提供します。

ダウン症市場の拡大を加速させている世界中の企業による多くの製品の発売や契約も開始されています。

例えば、

  • 2017 年 4 月、イルミナ社はヨーロッパで VeriSeq NIPT ソリューションを発売しました。発売された製品は、染色体異常のスクリーニングに使用される CE-IVD マークの次世代シーケンシング技術ベースのアプローチであり、妊娠 10 週以内の染色体状態に関する正確な情報を提供するのに有効であることが証明されています。この製品の発売により、同社の製品ポートフォリオが強化され、世界中のダウン症候群市場に根付くことができました。

市場プレーヤーによるコラボレーション、製品の発売、事業拡大、賞や表彰、合弁事業、その他の戦略は、ダウン症候群市場における企業市場を強化しており、組織がダウン症候群向けの製品やサービスを改善するメリットももたらしています。

SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

Sample Image 画像をクリックすると拡大します
  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

目次

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of EUROPE Down syndrome MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. treatment of Down syndrome LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. MARKET END USER COVERAGE GRID
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. Europe DOWN SYNDROME MARKET: Pipeline analysis
    1. PIPELINE PRODUCTS IMPACT ANALYSIS
    2. NNI-351
    3. ASPARAGINASE
    4. ANVS-401
    5. QUILLIVANT XR
    6. TOFACITINIB
    7. MEMANTINE HYDROCHLORIDE
    8. NICOTINE
    9. AEF0217
    10. ACI-24
  5. Europe DOwn syndrome Market: Laws and regulations
  6. Market Overview
    1. Drivers
      1. increasing prevalence OF DOWN syndrome
      2. rising demand of effective therapies
      3. rising awareness about the diseasE
      4. technological ADVANCEMENTS
      5. increasing government support
    2. RESTRAINTS
      1. UNAVAILABILITY OF any specific treatment
      2. Side Effects Associated With Down Syndrome Treatment Therapies
      3. high cost of diagnosis
    3. opportunities
      1. STRATEGIC INITIATIVES BY MARKET PLAYERS
      2. increasing research and development
      3. presence of pipeline therapies
      4. presence of reimbursement
    4. challenGes
      1. Lack of Skilled Proffessionals
      2. Long Process for Product Launch
      3. Transfer of COVID-19 Infections by Diagnostic Methods
  7. Impact of COVID-19 on Europe Down Syndrome Market
    1. Price Impact
    2. Impact on Supply Chain
    3. Impact on Demand
    4. Strategic Decisions for Manufacturers
    5. Conclusion
  8. Europe Down syndrome MARKET, BY disease Type
    1. overview
    2. trisomy 21
    3. translocation Down syndrome
    4. mosaic Down syndrome
  9. Europe Down syndrome MARKET, BY treatment
    1. overview
    2. diagnosis
      1. Screening Tests
        1. First Trimester
          1. Blood Test
          2. Nuchal Translucency Testing
        2. Integrated Screening Test
          1. First Trimester
          2. Second Trimester
        3. The Triple Screen or Quadraple Screen Test
        4. Ultrasound
        5. Cell Free DNA
      2. Diagnostic Tests
        1. Chronic Villus Sampling
        2. Amniocentesis
        3. Precutaneous Umbical Cord Sampling
    3. therapy
      1. Early Intervention Therapy
        1. Speech-Language Therapy
        2. Physical Therapy
        3. Occupational Therapy
        4. Others
      2. Assistive Technology
        1. Hearing Aids
        2. Glasses
        3. Others
      3. Surgery
        1. Atrioventricular Septal Defect (AVSD)
        2. Duodenal Atresia
        3. Others
      4. Others
  10. Europe Down syndrome MARKET, BY end user
    1. overview
    2. hospital
    3. clinics
    4. homecare setting
    5. others
  11. Europe Down syndrome MARKET, BY distribution channel
    1. overview
    2. direct tender
    3. retail sales
    4. others
  12. EUROPE Down syndrome MARKET, by Geography
    1. europe
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Russia
      7. Poland
      8. Switzerland
      9. Netherlands
      10. Hungary
      11. Austria
      12. Norway
      13. Ireland
      14. Turkey
      15. Lithuania
      16. Rest of Europe
  13. Europe Down syndrome market: COMPANY landscape
    1. company share analysis: Europe
  14. company profile
    1. F. Hoffmann-La Roche Ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. Company ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. PerkinElmer Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. Illumina, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    4. Thermo Fisher Scientific Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    5. Myriad Genetics, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    6. Abbott
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    7. Abnova Corporation
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. ASDclinic.co.uk
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENT
    9. AtilaBiosystems
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    10. Boston Children's Hospital
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    11. Boys Town National Research Hospital
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    12. Children's Hospital Colorado
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    13. Demeditec Diagnostics GmbH
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    14. Down Syndrome Cork
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    15. Mayo Clinic Health System
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENTS
    16. Natera, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    17. Next Biosciences
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    18. Novus Biologicals (A Subsidiary of Bio-Techne)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    19. Kid Sense Child Development Corporation Pty Ltd
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENT
    20. Physio.co.uk.
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENT
    21. Symbol
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
      3. RECENT DEVELOPMENT
  15. questionnaire
  16. related reports

表のリスト

TABLE 1 Europe Down syndrome market: Pipeline Analysis

TABLE 2 REGULATION imposed by several regulatory agencies in different regions

TABLE 3 Europe Down Syndrome Market, By Disease Type, 2019-2028 (USD Million)

TABLE 4 Europe Trisomy 21 in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 5 Europe Translocation Down Syndrome in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 6 Europe Mosaic Down Syndrome in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 7 Europe Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 8 Europe Diagnosis in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 9 Europe Diagnosis in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 10 Europe Diagnosis in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 11 Europe First Trimester in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 12 Europe Integrated Screening Test in Diagnosis in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 13 Europe Diagnostic Tests in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 14 Europe Therapy in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 15 Europe Therapy in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 16 Europe Early Intervention Therapy in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 17 Europe Assistive Technology in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 18 Europe Surgery in Down Syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 19 Europe Therapy in Down Syndrom Market, By End User, 2019-2028 (USD Million)

TABLE 20 Europe Hospital in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 21 Europe Clinics in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 22 Europe Homecare Setting in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 23 Europe Therapy Centers in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 24 Europe Others in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 25 Europe Down Syndrome Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 26 Europe Direct Tender in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 27 Europe Retail Sales in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 28 Europe Others in Down Syndrome Market, By Region, 2019-2028 (USD Million)

TABLE 29 europe Down syndrome Market, By Country, 2019-2028 (USD Million)

TABLE 30 europe Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 31 europe Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 32 europe diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 33 europe screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 34 europe first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 35 europe integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 36 europe diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 37 europe therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 38 europe early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 39 europe assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 40 europe surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 41 europe Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 42 europe Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 43 germany Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 44 germany Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 45 germany diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 46 germany screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 47 germany first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 48 germany integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 49 germany diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 50 germany therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 51 germany early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 52 germany assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 53 germany surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 54 germany Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 55 germany Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 56 U.K. Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 57 U.K. Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 58 U.K. diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 59 U.K. screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 60 U.K. first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 61 U.K. integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 62 U.K. diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 63 U.K. therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 64 U.K. early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 65 U.K. assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 66 U.K. surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 67 U.K. Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 68 U.K. Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 69 france Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 70 france Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 71 france diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 72 france screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 73 france first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 74 france integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 75 france diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 76 france therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 77 france early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 78 france assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 79 france surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 80 france Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 81 france Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 82 italy Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 83 italy Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 84 italy diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 85 italy screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 86 italy first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 87 italy integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 88 italy diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 89 italy therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 90 italy early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 91 italy assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 92 italy surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 93 italy Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 94 italy Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 95 spain Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 96 spain Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 97 spain diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 98 spain screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 99 spain first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 100 spain integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 101 spain diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 102 spain therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 103 spain early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 104 spain assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 105 spain surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 106 spain Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 107 spain Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 108 russia Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 109 russia Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 110 russia diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 111 russia screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 112 russia first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 113 russia integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 114 russia diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 115 russia therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 116 russia early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 117 russia assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 118 russia surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 119 russia Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 120 russia Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 121 poland Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 122 poland Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 123 poland diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 124 poland screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 125 poland first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 126 poland integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 127 poland diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 128 poland therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 129 poland early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 130 poland assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 131 poland surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 132 poland Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 133 poland Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 134 switzerland Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 135 switzerland Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 136 switzerland diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 137 switzerland screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 138 switzerland first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 139 switzerland integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 140 switzerland diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 141 switzerland therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 142 switzerland early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 143 switzerland assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 144 switzerland surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 145 switzerland Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 146 switzerland Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 147 netherlands Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 148 netherlands Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 149 netherlands diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 150 netherlands screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 151 netherlands first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 152 netherlands integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 153 netherlands diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 154 netherlands therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 155 netherlands early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 156 netherlands assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 157 netherlands surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 158 netherlands Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 159 netherlands Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 160 hungary Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 161 hungary Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 162 hungary diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 163 hungary screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 164 hungary first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 165 hungary integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 166 hungary diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 167 hungary therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 168 hungary early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 169 hungary assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 170 hungary surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 171 hungary Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 172 hungary Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 173 austria Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 174 austria Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 175 austria diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 176 austria screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 177 austria first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 178 austria integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 179 austria diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 180 austria therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 181 austria early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 182 austria assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 183 austria surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 184 austria Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 185 austria Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 186 norway Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 187 norway Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 188 norway diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 189 norway screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 190 norway first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 191 norway integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 192 norway diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 193 norway therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 194 norway early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 195 norway assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 196 norway surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 197 norway Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 198 norway Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 199 ireland Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 200 ireland Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 201 ireland diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 202 ireland screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 203 ireland first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 204 ireland integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 205 ireland diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 206 ireland therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 207 ireland early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 208 ireland assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 209 ireland surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 210 ireland Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 211 ireland Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 212 turkey Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 213 turkey Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 214 turkey diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 215 turkey screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 216 turkey first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 217 turkey integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 218 turkey diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 219 turkey therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 220 turkey early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 221 turkey assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 222 turkey surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 223 turkey Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 224 turkey Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 225 lithuania Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

TABLE 226 lithuania Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 227 lithuania diagnosis in Down SYNDROME MARKET, By Treatment, 2019-2028 (USD Million)

TABLE 228 lithuania screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 229 lithuania first trimester in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 230 lithuania integrated screening tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 231 lithuania diagnostic tests in Down syndrome Market, By Treatment, 2019-2028 (USD Million)

TABLE 232 lithuania therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 233 lithuania early intervention therapy in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 234 lithuania assistive technology in Down syndrome Market, By treatment, 2019-2028 (USD Million)

TABLE 235 lithuania surgery in Down SYNDROME MARKET, By treatment, 2019-2028 (USD Million)

TABLE 236 lithuania Down syndrome Market, By End User, 2019-2028 (USD Million)

TABLE 237 lithuania Down SYNDROME MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 238 rest of europe Down SYNDROME MARKET, By disease type, 2019-2028 (USD Million)

図表一覧

FIGURE 1 Europe DOWN SYNDROME MARKET: SEGMENTATION

FIGURE 2 EUROPE DOWN SYNDROME MARKET : DATA TRIANGULATION

FIGURE 3 Europe Down syndrome Market: DROC ANALYSIS

FIGURE 4 Europe Down syndrome market: Europe VS. REGIONAL MARKET ANALYSIS

FIGURE 5 Europe Down syndrome Market: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE Down syndrome MARKET: MULTIVARIATE MODELLING

FIGURE 7 EUROPE Down syndrome MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE DOWN SYNDROME MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE down syndrome Market: MARKET END UsER COVERAGE GRID

FIGURE 10 EUROPE DOWN SYNDROME MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 Europe Down syndrome market: SEGMENTATION

FIGURE 12 Increasing PREVALENCE of Down syndrome and Other Related Disorders and Rising Demand for Effective therapies is DRIVing THE Europe Down syndrome MARKET IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 trisomy 21 SEGMENT is expected to account for the largest share of the Europe DOWN SYNDROME MARKET in 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGEs OF EUROPE Down syndrome market

FIGURE 15 Europe Down syndrome market: BY disease type, 2020

FIGURE 16 Europe Down syndrome market: BY disease type, 2020-2028 (USD Million)

FIGURE 17 Europe Down syndrome market: BY disease type, CAGR (2020-2028)

FIGURE 18 Europe Down syndrome market: BY disease type, LIFELINE CURVE

FIGURE 1 Europe Down syndrome market: BY treatment, 2020

FIGURE 2 Europe Down syndrome market: BY treatment, 2020-2028 (USD Million).

FIGURE 3 Europe Down syndrome market: BY treatment, CAGR (2020-2028)

FIGURE 4 Europe Down syndrome market: BY treatment, LIFELINE CURVE

FIGURE 5 Europe Down syndrome market: BY end user, 2020

FIGURE 6 Europe Down syndrome market: BY end user, 2020-2028 (USD Million)

FIGURE 7 Europe Down syndrome market: BY end user, CAGR (2020-2028)

FIGURE 8 Europe Down syndrome market: BY end user, LIFELINE CURVE

FIGURE 9 Europe Down syndrome market: BY distribution channel, 2020

FIGURE 10 Europe Down syndrome market: BY distribution channel, 2020-2028 (USD Million)

FIGURE 11 Europe Down syndrome market: BY distribution channel, CAGR (2020-2028)

FIGURE 12 Europe Down syndrome market: BY distribution channel, LIFELINE CURVE

FIGURE 13 europe Down syndrome market: SNAPSHOT (2020)

FIGURE 14 europe Down syndrome market: BY COUNTRY (2020)

FIGURE 15 europe Down syndrome market: BY COUNTRY (2021 & 2028)

FIGURE 16 europe Down syndrome market: BY COUNTRY (2021 & 2028)

FIGURE 17 europe Down syndrome market: BY treatment (2021-2028)

FIGURE 18 Europe Down syndrome market: company share 2020 (%)

詳細情報を見る Right Arrow

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

関連ページを閲覧する

Banner